41 results
S-1/A
EX-10.10
CADL
Candel Therapeutics Inc
16 Jul 21
IPO registration (amended)
6:07am
Materials
ARTICLE VI
Section 6.1 Landlord’s Services
Section 6.2 Extraordinary Use
Section 6.3 Interruption: Delay
Section 6.4 Additional Services … - Certificate of Insurance
H - Electronic Funds Transfer (EFT) Form
K-1 - Hazardous Materials Requiring Prior Notice to Landlord
K-2 - Prohibited Hazardous
S-1
EX-10.10
CADL
Candel Therapeutics Inc
25 Jun 21
IPO registration
5:28pm
Tenant’s Audit Rights
ARTICLE V
Section 5.1 Permitted Use
Section 5.2 Restrictions on Use
Section 5.3 Hazardous Materials
ARTICLE VI
Section 6.1 … Transfer (EFT) Form
K-1 - Hazardous Materials Requiring Prior Notice to Landlord
K-2 - Prohibited Hazardous Materials
J - List of Permitted
DEFA14A
CADL
Candel Therapeutics Inc
2 Sep 22
Additional proxy soliciting materials
8:33am
Additional Materials
Soliciting Material under §240.14a-12
CANDEL THERAPEUTICS, INC.
(Name of registrant as specified in its charter)
(Name of Person(s … with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
CANDEL THERAPEUTICS, INC
8-K
CADL
Candel Therapeutics Inc
9 May 23
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
5:02pm
by stockholders for inclusion in the Company’s proxy materials (“Stockholder Notice”) in accordance with Rule 14a-8 under the Securities Exchange Act … for inclusion in the proxy materials for the 2023 Annual Meeting. Any Stockholder Notice must comply with the specific requirements set forth in the Bylaws
DEF 14A
9vy6cdx 4fiqyrrd
2 Sep 22
Definitive proxy
8:30am
10-Q
zii771wdk0p5wkg839h
8 Sep 21
Quarterly report
8:37am
10-K
EX-10.11
dgpga rmdcrj8gsjoqmo
29 Mar 22
Annual report
8:46am
10-K
fn7q2kbhhp kfu8w8ge
29 Mar 22
Annual report
8:46am